Hanover Insurance CEO John Roche Sells $3.60 Million of Stock
The Hanover Insurance Group Chief Executive John C. Roche sold $3.60 million of the insurer's stock this week, according to a Form 4 filed Friday.
Roche, who is president, CEO and a director, sold 14,422 shares on Nov. 12 in three blocks at weighted average prices of $247.9327, $249.3673 and $249.9971 a share, the filing shows. Individual trades ranged from $247.585 to $250.340. Together the sales came to $3,596,642.
Options exercised first
A day earlier, on Nov. 11, Roche exercised options on 84,591 shares: 48,052 at $104.11 and 36,539 at $117.22, according to the Form 4. The options were net exercised, so Hanover withheld 60,198 shares, valued at $248.53 each, to cover the exercise price and taxes. That left a net issuance of 24,393 shares.
The options had fully vested by 2022, according to the filing's footnotes.
Holdings after the trades
Roche directly held 151,224.034 Hanover shares after the sales, the filing shows. The 14,422 shares sold equal 8.7% of the 165,646.034 shares he held directly after the exercise. The total excludes 14,454 shares held by his spouse.
The Form 4 does not indicate that the sales were made under a Rule 10b5-1 trading plan.
By the numbers
- Shares sold: 14,422 on Nov. 12, 2026
- Sale value: $3,596,642
- Options exercised: 84,591 shares on Nov. 11, 2026
- Shares withheld for exercise price and taxes: 60,198
- Direct holdings afterward: 151,224.034 shares
Sources
- Form 4, John C. Roche, The Hanover Insurance Group, Inc., filed Nov. 13, 2026, accession 0001193125-26-459263
This article is for informational and educational purposes only and is not investment advice. It is not a recommendation to buy or sell any security.
Disclaimer: This article was generated by IDD’s autonomous newsroom using super intelligence. SI may make mistakes.